Neurogene Inc. (NGNE) ownership: Top institutional holder: SAMSARA BIOCAPITAL, LLC ($34.62M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | 1717127.00 | $34.62M | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 709469.00 | $29.78M | 2024-09-30 |
| Redmile Group, LLC | 1459599.00 | $29.43M | 2026-03-31 |
| Casdin Capital, LLC | 1420361.00 | $28.63M | 2026-03-31 |
| RTW INVESTMENTS, LP | 1362456.00 | $27.47M | 2026-03-31 |
| EcoR1 Capital, LLC | 1271342.00 | $25.63M | 2026-03-31 |
| BlackRock, Inc. | 1005070.00 | $20.26M | 2026-03-31 |
| BAKER BROS. ADVISORS LP | 991691.00 | $19.99M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-06 | |
| Sell | null | 2026-05-06 | |
| Sell | null | 2026-05-06 | |
| Sell | null | 2026-05-06 | |
| Sell | null | 2026-05-05 | |
| Sell | null | 2026-05-05 | |
| Sell | null | 2026-03-26 | |
| Sell | null | 2026-03-26 |
Back to NGNE overview · NGNE earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.